[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-340846-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-340846-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","modulation-of-macrophage-metabolism-as-an-emerging-immunotherapy-strategy-for-cancer-review","Modulation of macrophage metabolism as an emerging immunotherapy strategy for cancer - Review","","Immunometabolism investigates how immune cells use nutrients to support growth and function. This Review examines the metabolic landscape of tumor-associated macrophages, emphasizing immunoregulatory pathways involving glucose, fatty acids, glutamine, and arginine, and the experimental tools used to perturb these programs to enhance antitumor immunity. It also addresses how metabolic inhibitors can confound interpretation of myeloid metabolic phenotypes and discusses limitations of the M1/M2 binary framework in vivo, guiding future strategy design.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/modulation-of-macrophage-metabolism-as-an-emerging-immunotherapy-strategy-for-cancer-review/340846/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/modulation-of-macrophage-metabolism-as-an-emerging-immunotherapy-strategy-for-cancer-review/340846.png","ImageObject",300,407,{"name":42,"@type":43},"Jiven","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-04","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What does the Review focus on regarding macrophages in cancer?","Question",{"text":63,"@type":64},"It focuses on tumor-associated macrophages (TAMs) and their immature precursors, highlighting how metabolic programs shape immunoregulatory roles within the tumor microenvironment.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which nutrients and metabolic pathways are discussed as immunoregulatory factors?",{"text":68,"@type":64},"The Review discusses the roles of glucose, fatty acids, glutamine, and arginine, and explains how these metabolic inputs relate to pro- or anti-inflammatory TAM phenotypes.",{"name":70,"@type":61,"acceptedAnswer":71},"Why might the M1/M2 macrophage classification be insufficient?",{"text":72,"@type":64},"The Review argues that a binary schema likely underestimates the variety of TAM states in vivo and that TAM immune phenotypes exist along a continuum rather than discrete categories.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},340846,1790412315,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":112,"preview_page_count":33,"preview_urls":145},1099513958607,"https://ap-avatar.wpscdn.com/avatar/100002390cf8733938c?x-image-process=image/resize,m_fixed,w_180,h_180&k=1778829742770036399","The Journal of Clinical Investigation REVIEW  \nModulation of macrophage metabolism as an emerging immunotherapy strategy for cancer  \nCorey Dussold, Kaylee Zilinger, Jillyn Turunen, Amy B. Heimberger, and Jason Miska  \nDepartment of Neurological Surgery and Lou and Jean Malnati Brain Tumor Institute at Northwestern Medicine, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago Illinois, USA.  \nImmunometabolism is a burgeoning field of research that investigates how immune cells harness nutrients to drive their growth and functions. Myeloid cells play a pivotal role in tumor biology, yet their metabolic influence on tumor growth and antitumor immune responses remains inadequately understood. This Review explores the metabolic landscape of tumor-associated macrophages, including the immunoregulatory roles of glucose, fatty acids, glutamine, and arginine, alongside the tools used to perturb their metabolism to promote antitumor immunity. The confounding role of metabolic inhibitors on our interpretation of myeloid metabolic phenotypes will also be discussed. A binary metabolic schema is currently used to describe macrophage immunological phenotypes, characterizing inflammatory M1 phenotypes, as supported by glycolysis, and immunosuppressive M2 phenotypes, as supported by oxidative phosphorylation. However, this classification likely underestimates the variety of states in vivo. Understanding these nuances will be critical when developing interventional metabolic strategies. Future research should focus on refining drug specificity and targeted delivery methods to maximize therapeutic efficacy.  \nTherapeutic potential of targeting macrophage metabolism in cancer  \nImmunometabolism is a rapidly growing area of study that exploreshow immune cells employ various nutrients to support their growth and functionality. The metabolic programming of immune cells has wide-ranging effects on different disease processes, anda true understanding of these processes is critical to the future of immunotherapies for diseases. In solid tumors, tumor-associated macrophages (TAMs) are abundant and control multiple aspects of tumor growth (1, 2), including immune suppression and evasion through mechanisms such as TGF-β and IL-10 (3–8); the promotion ofangiogenesis through the secretion of VEGF (9–12), which mediates resistance to chemotherapy by protecting tumors from oxidative stress; and the promotion of tumor growth after radiation (13–18) . Despite their central role in tumor biology, we still lack a proper understanding of how TAM metabolism influences tumor growth and antitumor immune responses. Understanding the specific metabolic functions in the tumor microenvironment (TME) is critical for developing tumor-extrinsic immune-mediated therapies to improve cancer outcomes.  \nConflict of interest: ABH serves on the advisory board of Caris Life Sciences and the WCG Oncology Advisory Board; receives royalty and milestone payments from DNAtrix for the licensing of patent no. 11,065,285; is supported by research grants from Celularity, Alnylam, and AbbVie, and receives consulting fees from Novocure and Istari Oncology. She additionally has active granted patents (no. 9,675,633, no. 9,399,662) and a patent pending (international applications PCT/US2022/019435 and US 63/158,642) .  \nCopyright: © 2024, Dussold et al. This is an open access article published under the terms of the Creative Commons Attribution 4.0 International License.  \nReference information: J Clin Invest. 2024;134(2):e175445 .  \n[https://doi.org/10.1172/JCI175445](https://doi.org/10.1172/JCI175445) .  \nTAMs coordinate an immunosuppressive TME Most circulating myeloid cells arise from stem cells in the bone marrow (termed hematopoietic lineage cells), and they include neutrophils, basophils, mast cells, dendritic cells, macrophages, and monocytes. In solid tumors, these immune cells play diverse roles in tumor progression, metastasis,","cbCaioX27AckfUNQ","https://ap.wps.com/l/cbCaioX27AckfUNQ","pdf",1300415,12,"English","# Modulation of macrophage metabolism as an emerging immunotherapy strategy for cancer\n## Therapeutic potential of targeting macrophage metabolism in cancer\n## TAMs coordinate an immunosuppressive TME\n## Aerobic glycolysis versus mitochondrial glucose oxidation in TAMs","[{\"question\":\"What does the Review focus on regarding macrophages in cancer?\",\"answer\":\"It focuses on tumor-associated macrophages (TAMs) and their immature precursors, highlighting how metabolic programs shape immunoregulatory roles within the tumor microenvironment.\"},{\"question\":\"Which nutrients and metabolic pathways are discussed as immunoregulatory factors?\",\"answer\":\"The Review discusses the roles of glucose, fatty acids, glutamine, and arginine, and explains how these metabolic inputs relate to pro- or anti-inflammatory TAM phenotypes.\"},{\"question\":\"Why might the M1/M2 macrophage classification be insufficient?\",\"answer\":\"The Review argues that a binary schema likely underestimates the variety of TAM states in vivo and that TAM immune phenotypes exist along a continuum rather than discrete categories.\"}]","Modulation of macrophage metabolism as an emerging immunotherapy strategy for cancer - Review | PDF",1790039133,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6c04dc93b3e776b7bcf382a5b019a336.webp",983,1315,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/eae41420a237df0e6bc029c7c391c6c8.webp",982,1314,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/14fd7db4ad289aafaae57d6c6eb4596e.webp",981,1312,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/099dd91c910e971962feef0952b72ee3.webp",980,1311]